Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately
Globe Newswire•19/10/2026•12:04 ET
1
Key Highlights
- ➤FTC, California, and Utah sued Hims & Hers over consumer disclosure practices
- ➤Hims & Hers shares fell $4.32, or 14.73%, to $25.00
- ➤FTC alleges Hims shared consumers’ health information with Meta, Snap, and others
- ➤Lead-plaintiff deadline is November 2, 2026, for investors with losses
NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 22025,and July 29, 2026 (the "Class Period").
Investors who purchased Hims & Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026.
Get started
Create a free account to read the full story.